|Podcasts|November 15, 2022
The Ins and Outs of Digital Twins
Author(s)Lisa Henderson, Andy Studna, Senior Editor
Chief Science Officer at Unlearn.AI, Dave Miller, discusses digital twins, their pros and cons for the industry, and developments in Bayesian design and adaptive trials for CDER and CBER.
Chief Science Officer at Unlearn.AI, Dave Miller, discusses digital twins, their pros and cons for the industry, and developments in Bayesian design and adaptive trials for CDER and CBER.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Content
Trending on Applied Clinical Trials Online
1
FDA Issues Draft Guidance to Advance Bayesian Methods in Clinical Trials
2
Women as the Missing Voice in Parkinson’s Disease
3
Rethinking Site Activation to Cut Startup Timelines
4
ACT Brief: AI Extends Trial Registries, Contract Bottlenecks Delay Activation, and Data Integration Pushes Integrated Care
5